Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory.

Hui L, Geiersbach KB, Downs-Kelly E, Gulbahce HE.

Arch Pathol Lab Med. 2017 Feb;141(2):274-278. doi: 10.5858/arpa.2016-0201-OA. Epub 2016 Dec 13.

PMID:
27959582
2.

Inconsistent Results With Different Secondary Reflex Assays for Resolving HER2 Status.

Willmore-Payne C, Damjanovich-Colmenares K, Pasi AV, Werner TL, Gulbahce HE, Downs-Kelly E, Geiersbach KB.

Am J Clin Pathol. 2016 Oct 22. pii: aqw177. [Epub ahead of print]

PMID:
27773872
3.

Genomic Copy Number Analysis of HER2-Equivocal Breast Cancers.

Geiersbach KB, Willmore-Payne C, Pasi AV, Paxton CN, Werner TL, Xu X, Wittwer CT, Gulbahce HE, Downs-Kelly E.

Am J Clin Pathol. 2016 Oct;146(4):439-47. doi: 10.1093/ajcp/aqw130. Epub 2016 Sep 10.

PMID:
27614666
4.

HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer.

Gulbahce HE, Factor R, Geiersbach K, Downs-Kelly E.

Arch Pathol Lab Med. 2016 Aug;140(8):741. doi: 10.5858/arpa.2016-0015-LE. No abstract available.

PMID:
27472230
5.

Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma.

Lynam-Lennon N, Bibby BA, Mongan AM, Marignol L, Paxton CN, Geiersbach K, Bronner MP, O'Sullivan J, Reynolds J, Maher SG.

Mol Med. 2016 May 23;22. doi: 10.2119/molmed.2016.00020.

PMID:
27254108
6.

Digitally guided microdissection aids somatic mutation detection in difficult to dissect tumors.

Geiersbach K, Adey N, Welker N, Elsberry D, Malmberg E, Edwards S, Downs-Kelly E, Salama M, Bronner M.

Cancer Genet. 2016 Jan-Feb;209(1-2):42-9. doi: 10.1016/j.cancergen.2015.12.004. Epub 2015 Dec 15.

PMID:
26767919
7.

N of 1 case reports of exceptional responders accrued from pancreatic cancer patients enrolled in first-in-man studies from 2002 through 2012.

Garrido-Laguna I, Tometich D, Hu N, Ying J, Geiersbach K, Whisenant J, Wang K, Ross JS, Sharma S.

Oncoscience. 2015 Mar 14;2(3):285-93. eCollection 2015 Mar 14.

PMID:
25897431
8.

Copy number assessment by competitive PCR with limiting deoxynucleotide triphosphates and high-resolution melting.

Zhou L, Palais RA, Paxton CN, Geiersbach KB, Wittwer CT.

Clin Chem. 2015 May;61(5):724-33. doi: 10.1373/clinchem.2014.236208. Epub 2015 Mar 10.

PMID:
25759466
9.

Differentiation of genetic abnormalities in early pregnancy loss.

Romero ST, Geiersbach KB, Paxton CN, Rose NC, Schisterman EF, Branch DW, Silver RM.

Ultrasound Obstet Gynecol. 2015 Jan;45(1):89-94. doi: 10.1002/uog.14713.

PMID:
25358469
10.

Neural tube defects and atypical deletion on 22q11.2.

Leoni C, Stevenson DA, Geiersbach KB, Paxton CN, Krock BL, Mao R, Rope AF.

Am J Med Genet A. 2014 Nov;164A(11):2701-6. doi: 10.1002/ajmg.a.36701. Epub 2014 Aug 13.

PMID:
25123577
11.

Juvenile granulosa cell tumors: immunoreactivity for CD99 and Fli-1 and EWSR1 translocation status: a study of 11 cases.

Jarboe EA, Hirschowitz SL, Geiersbach KB, Wallander ML, Tripp SR, Layfield LJ.

Int J Gynecol Pathol. 2014 Jan;33(1):11-5. doi: 10.1097/PGP.0b013e31828309e6.

PMID:
24300529
12.

A mill based instrument and software system for dissecting slide-mounted tissue that provides digital guidance and documentation.

Adey N, Emery D, Bosh D, Callahan S, Schreiner J, Chen Y, Greig A, Geiersbach K, Parry R.

BMC Clin Pathol. 2013 Nov 5;13(1):29. doi: 10.1186/1472-6890-13-29.

PMID:
24188417
13.

Subjectivity in chromosome band-level estimation: a multicenter study.

Geiersbach KB, Gardiner AE, Wilson A, Shetty S, Bruyère H, Zabawski J, Saxe DF, Gaulin R, Williamson C, Van Dyke DL.

Genet Med. 2014 Feb;16(2):170-5. doi: 10.1038/gim.2013.95. Epub 2013 Jul 25.

PMID:
23887773
14.

Prediction of lung cancer histological types by RT-qPCR gene expression in FFPE specimens.

Wilkerson MD, Schallheim JM, Hayes DN, Roberts PJ, Bastien RR, Mullins M, Yin X, Miller CR, Thorne LB, Geiersbach KB, Muldrew KL, Funkhouser WK, Fan C, Hayward MC, Bayer S, Perou CM, Bernard PS.

J Mol Diagn. 2013 Jul;15(4):485-97. doi: 10.1016/j.jmoldx.2013.03.007. Epub 2013 May 20.

PMID:
23701907
15.

Diagnostic utility of microsatellite genotyping for molar pregnancy testing.

Furtado LV, Paxton CN, Jama MA, Tripp SR, Wilson AR, Lyon E, Jarboe EA, Thaker HM, Geiersbach KB.

Arch Pathol Lab Med. 2013 Jan;137(1):55-63. doi: 10.5858/arpa.2012-0047-OA.

PMID:
23276175
16.

Rapid aneusomy detection in products of conception using the KaryoLite™ BACs-on-Beads™ assay.

Paxton CN, Brothman AR, Geiersbach KB.

Prenat Diagn. 2013 Jan;33(1):25-31. doi: 10.1002/pd.4003. Epub 2012 Nov 8.

PMID:
23138848
18.

Aneuploidy detection in paraffin embedded tissue from products of conception by mini-STR genotyping.

Furtado LV, Jama MA, Paxton CN, Wilson AA, Gardiner AE, Lyon E, Geiersbach KB.

Fetal Pediatr Pathol. 2013 Apr;32(2):133-50. doi: 10.3109/15513815.2012.681428. Epub 2012 May 18.

PMID:
22607361
19.

FOXL2 mutation and large-scale genomic imbalances in adult granulosa cell tumors of the ovary.

Geiersbach KB, Jarboe EA, Jahromi MS, Baker CL, Paxton CN, Tripp SR, Schiffman JD.

Cancer Genet. 2011 Nov;204(11):596-602. doi: 10.1016/j.cancergen.2011.10.002.

PMID:
22200085
20.

Microsatellite instability and colorectal cancer.

Geiersbach KB, Samowitz WS.

Arch Pathol Lab Med. 2011 Oct;135(10):1269-77. doi: 10.5858/arpa.2011-0035-RA. Review.

PMID:
21970482

Supplemental Content

Loading ...
Support Center